ConductScience.org, home

Trial · NCT03854851

NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis

NCT03854851, Phase 4, Unknown, China Medical University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis. Trials, record NCT03854851. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03854851

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
NALDEBAIN for Postoperative Pain Management in Take Down of Anastomosis
NCT number
NCT03854851
Status
Unknown
Phases
Phase 4
Enrollment
40 participants, estimated
Lead sponsor
China Medical University Hospital
Conditions
Postoperative Pain
Interventions
Naldebain, Morpine
First posted
2019-02-26
Last updated
2019-02-26

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySupplemental analgesicsFrom Day 0 to Day 7The consumption of total amount (mg) of supplemental analgesics administered after surgery.
SecondaryPain assessment: VAS2 hours after surgeryUsing visual analog scale (VAS) with grades from 0 (no pain) to 10 (worst pain)
SecondaryPain assessment: VAS6 hours after surgeryUsing visual analog scale (VAS) with grades from 0 (no pain) to 10 (worst pain)
SecondaryPain assessment: VAS24 hours after surgeryUsing visual analog scale (VAS) with grades from 0 (no pain) to 10 (worst pain)
SecondaryPain assessment: VASFrom Day 2 to Day 7Using visual analog scale (VAS) with grades from 0 (no pain) to 10 (worst pain), once daily
SecondaryPain assessment: area under the curve of VASFrom post-OP to Day 7Pain assessment (time-specific pain intensity) calculated as the area under the curve of VAS pain intensity scores through 7 days after surgery
SecondaryPatient satisfaction: frequency of each optionDay 7Calculating the frequency of each option: highly satisfied, satisfied, uncertain, dissatisfied and very dissatisfied
Secondaryfrequency of adverse eventFrom Day-1 to Day 7Recording the frequency of treatment-emergent adverse event (TEAE)
OtherTime of first fartingFrom post-OP to Day 7Observing when patients are able to pass gas after surgery
OtherDate of dischargeFrom post-OP to Day 7Observing when the condition of patients is good enough to discharge

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03854851

GET https://conductscience.org/api/trials/v1/NCT03854851/registered